Bayer acquires Max Planck spin-off Targenomix
Collaboration is followed by acquisition: German pharmaceutical and chemical company Bayer has bought the start-up Targenomix. The two companies have already been working together since the spin-off from the Max Planck Institute of Molecular Plant Physiology in 2014. Targenomix uses systems biology and bioinformatics methods to identify new molecular targets for crop protection products.